Understanding the importance of quality assurance, AltaBioscience strives to maintain the following internationally recognised standards. They demonstrate our ability to consistently provide products and services that meet a customer’s specification, as well as our aim to enhance customer satisfaction by continuously improving our operations.
ISO/IEC 17025:2017 accredited
Technical competence in amino acid analysis and protein sequencing.
ISO/IEC 9001:2015 certification
Quality management system for the company.
Our quality management standards are of particular interest to those who are working in drug development and biotechnology. However, should your specification not require an ISO standard, you will benefit by knowing that the work we carry out on your behalf will conform to good laboratory practice.
We invite clients to visit our laboratories and also welcome quality assurance (QA) audits on their behalf *.
Please contact us to arrange a visit.
Copies of our certificates are available below:
PDF copy of the ISO 9001:2015 certificate
PDF copy of the ISO 17025:2017 certificate
If you have any questions regarding additional quality requirements, please contact our Quality Manager by emailing info@altabioscience.com
*We reserve the right to apply a discretionary charge for external audits.
Latest news
AltaBioscience Joins the National Alternative Protein Innovation Centre (NAPIC) as an Industrial Partner
AltaBioscience, a global analytical testing laboratory accredited to ISO 17025:2017 in amino acid analysis, announces its partnership with NAPIC to support the alternative protein sector. Read more in this latest article.
AltaBioscience Announces Dr Lisa Mansell as New Managing Director
AltaBioscience, a leading provider of custom synthesis and analytical services for the life science, food and alternative protein industries, is pleased to announce the appointment of Dr Lisa Mansell as the new Managing Director. Dr Lisa Mansell will be succeeding Mrs Marion Peak, who is retiring after a distinguished tenure with the company.
Cyclic Peptide Therapeutics in Drug Discovery
Why are cyclic peptide therapeutics gaining momentum in drug discovery? Learn how they compare to linear peptides and other drug modalities plus view a recent example of protein-protein interaction inhibitor that we have recently synthesised.